3Hopkins S. Clinical toleration and safety of azithromycin Am J Med, 1991,91 (Suppl 3) :40～45.
4Fould G,Shepard RM,Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues J Antimicrod Chemother, 1990,25 (Suppl) :73～82.
5Khair OA,Devalia JL,Abdelaziz MM,et al.Effects of erythromycin on Haemophilus influenzae endotoxin-induced release of IL-6,IL-8 and SICAM-1 by cultured human bronchial epithelial cells.Eur Respir J,1995,8:1451-1457.
6Culic O,Erakovic V,Parnham MJ.Anti-inflammatory effects of macrolide antibiotics.Eur J Pharmacol,2001,429:209-229.26 Tsang KW,Ho PI,Chan KN,et al.A pilot study of low-dose erythromycin in bronchiectasis.Eur Respir J,1999,13:361-364.27 Wolter J,Seeney S,Be
7Khair OA,Devalia JL,Abdelazia MM,et al.Effect of erythromycin on Haemophilus influenzae endotoxin-induced released of IL-6/IL-8 and Sicam-1 by cultured human bronchial epithelial cells.Europen Respir J,1995,8:1451-1457.
8Sakito O,Kadota J,Kohno S,et al.Interleukin 1 beta,tumor necrosis factor alpha,and interleukin 8 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis: a potential mechanism of macrolide therapy.Respiration,1996,63:42-48.
9Schultz MJ,Speelman P,Hack CE,et al.Intravenous infusion of erythromycin inhibits CXC chemokine production,but aguement neutrophil degranulation in whole blood stimulated with streptococcus pneumonia.J Antimicrob Chemother,2000,46:235-240.
10Sugihura E.Effects of macrolide aqntibiotics on neutrophils function in human peripheral blood.Kansenshogaku Zasshi,1997,71:329-336.
